Zurich, Switzerland

Susanne Andrea Meile

This inventor holds 1 USPTO granted patent. Top assignee: ETH Zurich. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Susanne Andrea Meile. Retrieved from https://idiyas.com/inventor/susanne-andrea-meile

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Susanne Andrea Meile: Innovator in Bacterial Infection Treatment

Introduction

Susanne Andrea Meile is a prominent inventor based in Zurich, Switzerland. She has made significant contributions to the field of medicine, particularly in the treatment of bacterial infections. Her innovative work has led to the development of a unique patent that addresses critical challenges in this area.

Latest Patents

Susanne holds a patent titled "Bacteriophages producing heterologous bacteriocins." This invention focuses on the use of bacteriophages to produce bacteriocins that can combat bacterial infections. The implications of her work are profound, as it offers new avenues for treating infections that are resistant to conventional antibiotics.

Career Highlights

Susanne is affiliated with ETH Zurich, a leading research institution known for its cutting-edge advancements in science and technology. Her role at ETH Zurich has allowed her to engage in groundbreaking research and collaborate with other experts in her field.

Collaborations

Throughout her career, Susanne has worked alongside notable colleagues, including Samuel Nando Kilcher and Matthew Stephen Dunne. These collaborations have further enriched her research and contributed to the success of her innovative projects.

Conclusion

Susanne Andrea Meile's contributions to the field of bacterial infection treatment exemplify the impact of innovation in medicine. Her patent and ongoing research continue to pave the way for new therapeutic strategies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…